BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7880042)

  • 1. [Can substitution practices be indicated in withdrawal programs for heroin addicts?].
    Boissonnas A
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():96-7. PubMed ID: 7880042
    [No Abstract]   [Full Text] [Related]  

  • 2. [Are maintenance substitution practices indicated in the framework of health care of drug addicts?].
    Déglon JJ
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():92-3. PubMed ID: 7880040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative value of buprenorphine and methadone].
    Reisinger M
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():23-5. PubMed ID: 7880007
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are substitution practices indicated in withdrawal within the framework of health care of drug addicts and according to what modalities?].
    Lauzon P
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():87-8. PubMed ID: 7880036
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Report on the buprenorphine substitution experience in urban medicine in Belgium].
    Reisinger M
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():46-7. PubMed ID: 7880017
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts.
    Nava F; Caldiroli E; Premi S; Lucchini A
    J Addict Dis; 2006; 25(2):9-16. PubMed ID: 16785214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Substitution study. Is it allowed to give placebos to junkies?].
    Ullmann R
    MMW Fortschr Med; 2003 Jul; 145(27-28):13. PubMed ID: 14587179
    [No Abstract]   [Full Text] [Related]  

  • 10. Pituitary gland volume among heroin users stabilised on substitution pharmacotherapy.
    Lorenzetti V; Lubman DI; Velakoulis D; Yücel M
    Drug Alcohol Depend; 2010 Jul; 110(1-2):164-6. PubMed ID: 20303678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportunistic diseases?] opportunisticinfections?].
    Boissonnas A
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():54-5. PubMed ID: 7880021
    [No Abstract]   [Full Text] [Related]  

  • 12. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: preliminary results of an open randomized study.
    Nava F; Manzato E; Leonardi C; Lucchini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1867-72. PubMed ID: 18801404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blessing or problem child? Substitution therapy for opiate-addicted patients].
    Pallenbach E
    Pharm Unserer Zeit; 2002; 31(1):90-5. PubMed ID: 11852662
    [No Abstract]   [Full Text] [Related]  

  • 15. [Buprenorphine as maintenance treatment in rehabilitation of heroin addicts].
    Bramness JG; Bachs LC; Waal H
    Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2452-4. PubMed ID: 12448114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of a new drug in the treatment of heroin addicts should not be obstructed by political dogmatism].
    Heilig M; Nilsson LH; Grönbladh L; Thulin SO; Sternebring B
    Lakartidningen; 2001 Sep; 98(37):3956-8. PubMed ID: 11586837
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of buprenorphine maintenance versus methadone maintenance.
    French MT
    Addiction; 2001 Oct; 96(10):1515-7. PubMed ID: 11599513
    [No Abstract]   [Full Text] [Related]  

  • 18. Buprenorphine for heroin addicts: the issue of illicit opioid abuse during maintenance.
    Cho E; Dermatis H; Galanter M
    Subst Abus; 2006 Jun; 27(1-2):1-3. PubMed ID: 17062539
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of heroin-dependent adolescents presenting for opiate substitution treatment.
    Smyth BP; Fagan J; Kernan K
    J Subst Abuse Treat; 2012 Jan; 42(1):35-44. PubMed ID: 21940134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Rorschach's test for heroin addicts treated by methadone: from reality to imaginary].
    Deslandes C; Gourarier L; Sanchez M; Lowenstein W
    Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B61-4. PubMed ID: 11104948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.